141 related articles for article (PubMed ID: 35525546)
1. Cellular thermal shift assay (CETSA) for determining the drug binding affinity using Ba/F3 clones stably expressing receptor pseudokinases.
Karvonen H; Raivola J; Ungureanu D
Methods Enzymol; 2022; 667():339-363. PubMed ID: 35525546
[TBL] [Abstract][Full Text] [Related]
2. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
Raivola J; Dini A; Salokas K; Karvonen H; Niininen W; Piki E; Varjosalo M; Ungureanu D
Cell Mol Life Sci; 2022 May; 79(5):276. PubMed ID: 35504983
[TBL] [Abstract][Full Text] [Related]
3. Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance.
Fleischmann M; Fischer M; Schnetzke U; Fortner C; Kirkpatrick J; Heidel FH; Hochhaus A; Scholl S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831215
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin and interleukin-3 induce distinct events in erythropoietin receptor-expressing BA/F3 cells.
Krosl J; Damen JE; Krystal G; Humphries RK
Blood; 1995 Jan; 85(1):50-6. PubMed ID: 7803809
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Ligand Binding to Pseudokinases Using a Thermal Shift Assay.
Lucet IS; Murphy JM
Methods Mol Biol; 2017; 1636():91-104. PubMed ID: 28730475
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
7. Application of the Cellular Thermal Shift Assay (CETSA) to validate drug target engagement in platelets.
Howes JM; Harper MT
Platelets; 2024 Dec; 35(1):2354833. PubMed ID: 38767506
[TBL] [Abstract][Full Text] [Related]
8. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.
Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG
Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838
[TBL] [Abstract][Full Text] [Related]
9. A synthetic peptide corresponding to a critical intracellular signaling region of the human IL-4 receptor inhibits IL-4-induced proliferation.
Izuhara K; Sakai M; Inaba R; Imamura T; Howard M; Harada N
Cell Immunol; 1995 Jul; 163(2):254-9. PubMed ID: 7606796
[TBL] [Abstract][Full Text] [Related]
10. Ba/F3 cells and their use in kinase drug discovery.
Warmuth M; Kim S; Gu XJ; Xia G; Adrián F
Curr Opin Oncol; 2007 Jan; 19(1):55-60. PubMed ID: 17133113
[TBL] [Abstract][Full Text] [Related]
11.
Lenz T; Stühler K
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628420
[TBL] [Abstract][Full Text] [Related]
12. Perspective on CETSA Literature: Toward More Quantitative Data Interpretation.
Seashore-Ludlow B; Axelsson H; Lundbäck T
SLAS Discov; 2020 Feb; 25(2):118-126. PubMed ID: 31665966
[TBL] [Abstract][Full Text] [Related]
13. Internal tandem duplication and tyrosine kinase domain mutations in
Takahashi S; Shirahama K
Biomed Rep; 2016 Jan; 4(1):83-86. PubMed ID: 26870340
[TBL] [Abstract][Full Text] [Related]
14. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.
Sheetz JB; Mathea S; Karvonen H; Malhotra K; Chatterjee D; Niininen W; Perttilä R; Preuss F; Suresh K; Stayrook SE; Tsutsui Y; Radhakrishnan R; Ungureanu D; Knapp S; Lemmon MA
Mol Cell; 2020 Aug; 79(3):390-405.e7. PubMed ID: 32619402
[TBL] [Abstract][Full Text] [Related]
15. Sensitivities to various epidermal growth factor receptor-tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor-tyrosine kinase inhibitor?
Banno E; Togashi Y; Nakamura Y; Chiba M; Kobayashi Y; Hayashi H; Terashima M; de Velasco MA; Sakai K; Fujita Y; Mitsudomi T; Nishio K
Cancer Sci; 2016 Aug; 107(8):1134-40. PubMed ID: 27240419
[TBL] [Abstract][Full Text] [Related]
16. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.
Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC
Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018
[TBL] [Abstract][Full Text] [Related]
17. Horizontal Cell Biology: Monitoring Global Changes of Protein Interaction States with the Proteome-Wide Cellular Thermal Shift Assay (CETSA).
Dai L; Prabhu N; Yu LY; Bacanu S; Ramos AD; Nordlund P
Annu Rev Biochem; 2019 Jun; 88():383-408. PubMed ID: 30939043
[TBL] [Abstract][Full Text] [Related]
18. Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma.
Plo I; Lautier D; Casteran N; Dubreuil P; Arock M; Laurent G
Oncogene; 2001 Oct; 20(46):6752-63. PubMed ID: 11709710
[TBL] [Abstract][Full Text] [Related]
19. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
20. Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay.
Shaw J; Leveridge M; Norling C; Karén J; Molina DM; O'Neill D; Dowling JE; Davey P; Cowan S; Dabrowski M; Main M; Gianni D
Sci Rep; 2018 Jan; 8(1):163. PubMed ID: 29317749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
